| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 5.07e-18 | 114 | 203 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.63e-17 | 124 | 203 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.80e-16 | 137 | 203 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 CASP7 USP17L5 USP17L6P USP17L22 CTSH USP17L15 USP17L8 | 6.12e-16 | 192 | 203 | 21 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 MMP17 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 SHH CASP7 USP17L5 ACE2 USP17L6P USP17L22 CTSH USP17L15 USP17L8 | 5.85e-08 | 654 | 203 | 24 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF460 ZNF226 ZNF623 PRDM2 TFCP2L1 CPHXL SAFB ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 NEUROD4 ZNF674 AIRE SIX1 PRDM5 TFCP2 ZNF404 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 CTCF ZNF718 ZNF425 ZNF335 TET1 ZKSCAN3 ZNF221 ZNF415 | 1.66e-06 | 1459 | 203 | 35 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF460 ZNF226 ZNF623 PRDM2 TFCP2L1 CPHXL ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 NEUROD4 ZNF674 SHOX SIX1 PRDM5 TFCP2 ZNF404 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 CTCF ZNF718 ZNF425 ZBED6 ZKSCAN3 ZNF221 ZNF415 | 6.00e-06 | 1412 | 203 | 33 | GO:0000981 |
| GeneOntologyMolecularFunction | hemoglobin alpha binding | 1.02e-05 | 5 | 203 | 3 | GO:0031721 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF460 HMGB2 ZNF226 ZNF623 TFCP2L1 CPHXL SAFB ZNF778 PLAG1 ZNF578 ZNF81 ZNF473 ZNF484 ZNF607 NEUROD4 SIX1 PRDM5 TFCP2 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 CTCF ZNF718 ZNF335 TET1 ZKSCAN3 ZNF221 ZNF415 | 1.39e-05 | 1271 | 203 | 30 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF460 ZNF226 ZNF623 TFCP2L1 CPHXL SAFB ZNF778 PLAG1 ZNF578 ZNF81 ZNF473 ZNF484 ZNF607 NEUROD4 SIX1 PRDM5 TFCP2 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 CTCF ZNF718 ZNF335 TET1 ZKSCAN3 ZNF221 ZNF415 | 2.48e-05 | 1244 | 203 | 29 | GO:0000978 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | FBXO40 RAD18 RNF168 MYCBP2 TRIM34 RNF113B ANKIB1 MGRN1 ATG5 TRAF7 RC3H2 RFPL4B TRIM9 TRIM17 | 6.02e-05 | 398 | 203 | 14 | GO:0061659 |
| GeneOntologyMolecularFunction | haptoglobin binding | 1.18e-04 | 10 | 203 | 3 | GO:0031720 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | FBXO40 RAD18 RNF168 MYCBP2 TRIM34 RNF113B ANKIB1 MGRN1 TRAF7 RC3H2 RFPL4B TRIM9 TRIM17 | 1.18e-04 | 372 | 203 | 13 | GO:0061630 |
| GeneOntologyMolecularFunction | hemoglobin binding | 1.61e-04 | 11 | 203 | 3 | GO:0030492 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | FBXO40 RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 ATG5 TRAF7 RC3H2 RFPL4B TRIM9 TRIM17 | 2.48e-04 | 512 | 203 | 15 | GO:0019787 |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 3.06e-04 | 3 | 203 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | oxygen carrier activity | 3.47e-04 | 14 | 203 | 3 | GO:0005344 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | FBXO40 RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 RFPL4B TRIM9 TRIM17 | 3.60e-04 | 473 | 203 | 14 | GO:0004842 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | FBXO40 RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 ATG5 TRAF7 RC3H2 RFPL4B TRIM9 TRIM17 | 3.72e-04 | 532 | 203 | 15 | GO:0016755 |
| GeneOntologyMolecularFunction | oxygen binding | 5.27e-04 | 37 | 203 | 4 | GO:0019825 | |
| GeneOntologyMolecularFunction | zinc ion binding | ZCCHC24 FBXO40 MYCBP2 TRIM34 PRDM2 BRCA1 ANKIB1 MMP17 TRAF7 CAD SLC4A8 TRIM42 SHH AIRE ACE2 CTCF TRIM9 TRIM17 TET1 CA5B | 7.85e-04 | 891 | 203 | 20 | GO:0008270 |
| GeneOntologyMolecularFunction | acyltransferase activity | FBXO40 RAD18 RNF168 NAA60 MYCBP2 TRIM34 RNF113B BRCA1 BRCA2 ANKIB1 MGRN1 ATG5 TRAF7 RC3H2 ELP3 RFPL4B TRIM9 TRIM17 | 9.81e-04 | 775 | 203 | 18 | GO:0016746 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.01e-03 | 5 | 203 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | supercoiled DNA binding | 1.50e-03 | 6 | 203 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.67e-03 | 84 | 203 | 5 | GO:0003684 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ZCCHC24 FBXO40 MYCBP2 TRIM34 PRDM2 BRCA1 ANKIB1 MMP17 TRAF7 MRE11 CAD SLC4A8 TRIM42 SHH AIRE ACE2 TH CTCF TRIM9 TRIM17 TET1 OGFOD1 CA5B | 2.31e-03 | 1189 | 203 | 23 | GO:0046914 |
| GeneOntologyMolecularFunction | histone modifying activity | 2.44e-03 | 229 | 203 | 8 | GO:0140993 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.42e-17 | 125 | 201 | 19 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.16e-16 | 144 | 201 | 19 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 RAD18 RNF168 DCAF8 MYCBP2 USP17L20 PTPN22 TRIM34 USP17L19 USP17L18 RNF113B BRCA1 USP17L17 USP42 ANKIB1 USP17L3 USP48 WDR77 MGRN1 ATG5 TRAF7 RC3H2 USP17L4 USP17L2 USP17L12 TRIM42 USP17L11 USP17L24 USP17L5 RFPL4B CCNF DCAF10 TRIM9 TRIM17 USP17L6P USP17L22 USP17L15 USP17L8 | 1.18e-13 | 1009 | 201 | 39 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 RAD18 RNF168 DCAF8 MYCBP2 USP17L20 PTPN22 TRIM34 USP17L19 USP17L18 RNF113B BRCA1 USP17L17 USP42 ANKIB1 USP17L3 DSCC1 USP48 WDR77 MGRN1 ATG5 TRAF7 RC3H2 USP17L4 USP17L2 USP17L12 TRIM42 USP17L11 USP17L24 USP17L5 RFPL4B CCNF DCAF10 TRIM9 TRIM17 USP17L6P USP17L22 USP17L15 USP17L8 | 1.79e-13 | 1074 | 201 | 40 | GO:0043687 |
| GeneOntologyBiologicalProcess | chromatin organization | LRWD1 RNF168 PHF20 NAA60 ATR HMGB1 HMGB2 KDM5D PRDM2 SAFB BRCA1 BRCA2 TASOR TADA3 ATG5 MRE11 BICRA TEX15 PRDM5 CTCF ZNF335 TET1 ATM DOT1L | 7.33e-06 | 896 | 201 | 24 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | LRWD1 RNF168 PHF20 NAA60 ATR HMGB1 HMGB2 KDM5D PRDM2 SAFB BRCA1 BRCA2 TAF2 TASOR TADA3 ATG5 MRE11 BICRA TEX15 PRDM5 CTCF ZNF335 TET1 ATM DOT1L | 1.49e-05 | 999 | 201 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 1.78e-05 | 6 | 201 | 3 | GO:1905323 | |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 5.74e-05 | 136 | 201 | 8 | GO:0000077 | |
| GeneOntologyBiologicalProcess | response to nitrosative stress | 7.33e-05 | 9 | 201 | 3 | GO:0051409 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ITGA6 HMGB1 HMGB2 PRPF6 TLR7 ZNF226 PRDM2 TFCP2L1 SAFB BRCA1 PLAG1 TAF2 ZNF473 ZNF484 NEUROD4 WNT2 SHH AIRE SHOX SIX1 PRDM5 TFCP2 ZNF668 CTCF ZNF335 TET1 PRKD1 ATM DOT1L | 8.46e-05 | 1390 | 201 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | DNA integrity checkpoint signaling | 9.01e-05 | 145 | 201 | 8 | GO:0031570 | |
| GeneOntologyBiologicalProcess | positive regulation of interferon-beta production | 9.20e-05 | 47 | 201 | 5 | GO:0032728 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 9.45e-05 | 2 | 201 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 9.45e-05 | 2 | 201 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 9.45e-05 | 2 | 201 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | RAD18 RNF168 DCAF8 MYCBP2 PTPN22 TRIM34 RNF113B BRCA1 ANKIB1 WDR77 MGRN1 ATG5 TRAF7 RC3H2 TRIM42 RFPL4B CCNF DCAF10 TRIM9 TRIM17 | 1.37e-04 | 811 | 201 | 20 | GO:0016567 |
| GeneOntologyBiologicalProcess | DNA repair | SMG1 RAD18 BRIP1 RNF168 ATR HMGB1 HMGB2 BRCA1 BRCA2 TAF2 TADA3 MRE11 TEX15 ZNF668 ATM DOT1L TDP1 | 2.15e-04 | 648 | 201 | 17 | GO:0006281 |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 2.82e-04 | 3 | 201 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 2.82e-04 | 3 | 201 | 2 | GO:0097695 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation involved in ureter development | 2.82e-04 | 3 | 201 | 2 | GO:2000729 | |
| GeneOntologyBiologicalProcess | negative thymic T cell selection | 3.07e-04 | 14 | 201 | 3 | GO:0045060 | |
| GeneOntologyBiologicalProcess | somite development | 3.18e-04 | 94 | 201 | 6 | GO:0061053 | |
| GeneOntologyCellularComponent | hemoglobin complex | 3.72e-06 | 12 | 199 | 4 | GO:0005833 | |
| GeneOntologyCellularComponent | DNA repair complex | 6.12e-05 | 23 | 199 | 4 | GO:1990391 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | RAD18 RNF168 DCAF8 BRCA1 BRCA2 ANKIB1 WDR77 MGRN1 TRAF7 DCAF8L2 CCNF DCAF10 | 1.48e-04 | 352 | 199 | 12 | GO:0000151 |
| GeneOntologyCellularComponent | haptoglobin-hemoglobin complex | 1.75e-04 | 12 | 199 | 3 | GO:0031838 | |
| GeneOntologyCellularComponent | Cul4-RING E3 ubiquitin ligase complex | 4.57e-04 | 38 | 199 | 4 | GO:0080008 | |
| GeneOntologyCellularComponent | BRCA1-B complex | 5.34e-04 | 4 | 199 | 2 | GO:0070532 | |
| GeneOntologyCellularComponent | condensed chromosome | 7.50e-04 | 307 | 199 | 10 | GO:0000793 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L20 INSIG1 TLR7 USP17L19 TMCC3 USP17L18 POM121 USP17L17 CYB5R3 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 SHH USP17L5 LRRC8D USP17L6P USP17L22 TNPO3 USP17L15 GABBR1 USP17L8 | 8.56e-04 | 1327 | 199 | 25 | GO:0042175 |
| GeneOntologyCellularComponent | XY body | 1.31e-03 | 23 | 199 | 3 | GO:0001741 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 1.32e-03 | 6 | 199 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 USP17L20 INSIG1 TLR7 USP17L19 TMCC3 USP17L18 POM121 USP17L17 CYB5R3 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 SHH USP17L5 LRRC8D USP17L6P USP17L22 USP17L15 GABBR1 USP17L8 | 1.33e-03 | 1293 | 199 | 24 | GO:0005789 |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.39e-03 | 86 | 199 | 5 | GO:0001673 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 USP17L20 INSIG1 TLR7 USP17L19 TMCC3 USP17L18 POM121 USP17L17 CYB5R3 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 SHH USP17L5 LRRC8D USP17L6P USP17L22 USP17L15 GABBR1 USP17L8 | 1.42e-03 | 1299 | 199 | 24 | GO:0098827 |
| HumanPheno | Abnormal prostate morphology | 3.06e-06 | 36 | 60 | 6 | HP:0008775 | |
| HumanPheno | Aplasia/Hypoplasia of the radius | 4.14e-06 | 82 | 60 | 8 | HP:0006501 | |
| HumanPheno | Breast carcinoma | 1.10e-05 | 67 | 60 | 7 | HP:0003002 | |
| HumanPheno | Abnormality of chromosome segregation | 1.48e-05 | 70 | 60 | 7 | HP:0002916 | |
| HumanPheno | Primary peritoneal carcinoma | 1.59e-05 | 14 | 60 | 4 | HP:0030406 | |
| HumanPheno | Aplasia/hypoplasia involving forearm bones | 1.83e-05 | 100 | 60 | 8 | HP:0006503 | |
| HumanPheno | Tumours of the breast | 1.95e-05 | 73 | 60 | 7 | HP:0010623 | |
| HumanPheno | Abnormality of chromosome stability | 3.83e-05 | 55 | 60 | 6 | HP:0003220 | |
| HumanPheno | Abnormal preputium morphology | 5.45e-05 | 36 | 60 | 5 | HP:0100587 | |
| HumanPheno | Chromosome breakage | 7.13e-05 | 38 | 60 | 5 | HP:0040012 | |
| HumanPheno | Fibroma | 8.71e-05 | 124 | 60 | 8 | HP:0010614 | |
| HumanPheno | Neoplasm of the breast | 8.83e-05 | 92 | 60 | 7 | HP:0100013 | |
| HumanPheno | Fibrous tissue neoplasm | 9.75e-05 | 126 | 60 | 8 | HP:0012316 | |
| HumanPheno | Acholic stools | 1.24e-04 | 9 | 60 | 3 | HP:0011985 | |
| HumanPheno | Ovarian neoplasm | 1.51e-04 | 70 | 60 | 6 | HP:0100615 | |
| HumanPheno | Functional intestinal obstruction | 1.76e-04 | 10 | 60 | 3 | HP:0005249 | |
| HumanPheno | Extrahepatic cholestasis | 1.76e-04 | 10 | 60 | 3 | HP:0012334 | |
| HumanPheno | Peritoneal abscess | 2.40e-04 | 11 | 60 | 3 | HP:0100592 | |
| HumanPheno | Abnormal circulating creatine concentration | 2.40e-04 | 11 | 60 | 3 | HP:0012113 | |
| HumanPheno | Abnormal fallopian tube morphology | 2.49e-04 | 27 | 60 | 4 | HP:0011027 | |
| HumanPheno | Prostate neoplasm | 2.88e-04 | 28 | 60 | 4 | HP:0100787 | |
| HumanPheno | Prostate cancer | 2.88e-04 | 28 | 60 | 4 | HP:0012125 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | BRIP1 SAMD9 ATR TRIO PTPN22 BRCA1 BRCA2 BICRA SHH SHOX WDR19 ZNF668 CTCF PRKD1 | 4.04e-04 | 436 | 60 | 14 | HP:0040065 |
| HumanPheno | Poor hand-eye coordination | 4.06e-04 | 3 | 60 | 2 | HP:0007057 | |
| MousePheno | chromosomal instability | 1.19e-06 | 109 | 137 | 9 | MP:0008866 | |
| MousePheno | abnormal chromosome stability | 1.87e-06 | 115 | 137 | 9 | MP:0010094 | |
| MousePheno | increased hemolymphoid system tumor incidence | 1.83e-05 | 191 | 137 | 10 | MP:0010296 | |
| MousePheno | increased lymphoma incidence | 3.36e-05 | 164 | 137 | 9 | MP:0012431 | |
| MousePheno | abnormal DNA repair | 4.13e-05 | 130 | 137 | 8 | MP:0008058 | |
| MousePheno | increased granulosa cell proliferation | 9.54e-05 | 2 | 137 | 2 | MP:0031019 | |
| MousePheno | absent vestibulocochlear ganglion | 9.54e-05 | 2 | 137 | 2 | MP:0004313 | |
| MousePheno | decreased cell proliferation | SMG1 BRIP1 ATR TLR7 BRCA1 BRCA2 TADA3 MRE11 USP17L2 GIT1 WNT2 SHH SIX1 CCNF KANK4 ATM DOT1L PTGES3 USP17L15 | 1.07e-04 | 739 | 137 | 19 | MP:0000352 |
| MousePheno | decreased follicular B cell number | 1.37e-04 | 51 | 137 | 5 | MP:0008174 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 8.94e-24 | 16 | 200 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 8.94e-24 | 16 | 200 | 13 | IPR006861 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 7.70e-19 | 70 | 200 | 17 | PS00972 |
| Domain | UCH | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.00e-18 | 71 | 200 | 17 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.00e-18 | 71 | 200 | 17 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.30e-18 | 72 | 200 | 17 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.30e-18 | 72 | 200 | 17 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 1.30e-18 | 72 | 200 | 17 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L8 | 8.72e-18 | 66 | 200 | 16 | IPR018200 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF234 PHF20 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZC3H7A ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 2.30e-10 | 775 | 200 | 31 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF234 PHF20 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZC3H7A ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 2.45e-10 | 777 | 200 | 31 | PS00028 |
| Domain | zf-C2H2 | ZNF234 PHF20 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 3.30e-10 | 693 | 200 | 29 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF234 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 3.41e-10 | 694 | 200 | 29 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF234 PHF20 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZC3H7A ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 4.42e-10 | 796 | 200 | 31 | IPR015880 |
| Domain | Znf_C2H2 | ZNF234 PHF20 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZC3H7A ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 5.81e-10 | 805 | 200 | 31 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF234 PHF20 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZC3H7A ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 6.35e-10 | 808 | 200 | 31 | SM00355 |
| Domain | - | ZNF234 ZNF460 ZNF226 ZNF623 PRDM2 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZNF668 ZNF630 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 9.57e-10 | 679 | 200 | 28 | 3.30.160.60 |
| Domain | KRAB | ZNF234 ZNF460 ZNF226 ZNF778 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 ZNF404 ZNF630 ZNF713 ZNF28 ZNF718 ZNF425 ZKSCAN3 ZNF221 | 1.11e-08 | 358 | 200 | 19 | PS50805 |
| Domain | KRAB | ZNF234 ZNF460 ZNF226 ZNF778 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 ZNF404 ZNF630 ZNF713 ZNF28 ZNF718 ZNF425 ZKSCAN3 ZNF221 | 1.11e-08 | 358 | 200 | 19 | PF01352 |
| Domain | KRAB | ZNF234 ZNF460 ZNF226 ZNF778 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 ZNF404 ZNF630 ZNF713 ZNF28 ZNF718 ZNF425 ZKSCAN3 ZNF221 | 1.80e-08 | 369 | 200 | 19 | SM00349 |
| Domain | KRAB | ZNF234 ZNF460 ZNF226 ZNF778 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 ZNF404 ZNF630 ZNF713 ZNF28 ZNF718 ZNF425 ZKSCAN3 ZNF221 | 1.88e-08 | 370 | 200 | 19 | IPR001909 |
| Domain | Znf_RING/FYVE/PHD | RAD18 RNF168 PHF20 MYCBP2 TRIM34 KDM5D RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 TRIM42 PHF6 AIRE RFPL4B TRIM9 TRIM17 | 2.34e-06 | 459 | 200 | 18 | IPR013083 |
| Domain | ZF_RING_1 | RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 TRIM42 RFPL4B TRIM9 TRIM17 | 3.22e-06 | 291 | 200 | 14 | PS00518 |
| Domain | ZF_RING_2 | RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 TRIM42 RFPL4B TRIM9 TRIM17 | 4.23e-06 | 298 | 200 | 14 | PS50089 |
| Domain | RING | RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 TRIM42 RFPL4B TRIM9 TRIM17 | 5.53e-06 | 305 | 200 | 14 | SM00184 |
| Domain | - | RAD18 RNF168 PHF20 MYCBP2 TRIM34 KDM5D RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 PHF6 AIRE RFPL4B TRIM9 TRIM17 | 7.18e-06 | 449 | 200 | 17 | 3.30.40.10 |
| Domain | Znf_RING_CS | RAD18 TRIM34 RNF113B BRCA1 TRAF7 RC3H2 TRIM42 RFPL4B TRIM9 TRIM17 | 1.05e-05 | 163 | 200 | 10 | IPR017907 |
| Domain | Znf_RING | RAD18 RNF168 MYCBP2 TRIM34 RNF113B BRCA1 ANKIB1 MGRN1 TRAF7 RC3H2 TRIM42 RFPL4B TRIM9 TRIM17 | 1.18e-05 | 326 | 200 | 14 | IPR001841 |
| Domain | Haemoglobin_b | 1.19e-05 | 5 | 200 | 3 | IPR002337 | |
| Domain | FATC | 1.19e-05 | 5 | 200 | 3 | PF02260 | |
| Domain | Globin-like | 2.10e-05 | 16 | 200 | 4 | IPR009050 | |
| Domain | FAT | 2.36e-05 | 6 | 200 | 3 | PS51189 | |
| Domain | FATC | 2.36e-05 | 6 | 200 | 3 | PS51190 | |
| Domain | FATC_dom | 2.36e-05 | 6 | 200 | 3 | IPR003152 | |
| Domain | PIK_FAT | 2.36e-05 | 6 | 200 | 3 | IPR014009 | |
| Domain | FATC | 2.36e-05 | 6 | 200 | 3 | SM01343 | |
| Domain | zf-C2H2_6 | ZNF234 PRDM2 ZNF778 ZNF578 ZFP90 ZNF473 ZNF607 PRDM5 ZNF404 ZNF668 ZSCAN10 ZNF718 ZNF425 | 3.55e-05 | 314 | 200 | 13 | PF13912 |
| Domain | ATM/Tel1 | 1.14e-04 | 2 | 200 | 2 | IPR015519 | |
| Domain | zf-C3HC4 | RAD18 RNF168 TRIM34 RNF113B BRCA1 MGRN1 TRAF7 TRIM42 TRIM9 TRIM17 | 1.50e-04 | 223 | 200 | 10 | PF00097 |
| Domain | Globin | 2.48e-04 | 12 | 200 | 3 | IPR000971 | |
| Domain | Globin | 2.48e-04 | 12 | 200 | 3 | PF00042 | |
| Domain | GLOBIN | 2.48e-04 | 12 | 200 | 3 | PS01033 | |
| Domain | ARM-type_fold | SMG1 ATR PSMD2 RRP12 TAF2 TNPO1 VEPH1 PPP2R5C MROH6 EIF5 ATM TNPO3 | 3.06e-04 | 339 | 200 | 12 | IPR016024 |
| Domain | - | 3.20e-04 | 13 | 200 | 3 | 1.10.490.10 | |
| Domain | Globin/Proto | 3.20e-04 | 13 | 200 | 3 | IPR012292 | |
| Domain | HMG_boxA_CS | 3.40e-04 | 3 | 200 | 2 | IPR017967 | |
| Domain | PI3/4_kinase_CS | 5.01e-04 | 15 | 200 | 3 | IPR018936 | |
| Domain | - | 6.11e-04 | 16 | 200 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.11e-04 | 16 | 200 | 3 | SM00146 | |
| Domain | - | 8.62e-04 | 40 | 200 | 4 | 4.10.1000.10 | |
| Domain | PI3_PI4_kinase | 8.77e-04 | 18 | 200 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 8.77e-04 | 18 | 200 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.77e-04 | 18 | 200 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 8.77e-04 | 18 | 200 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 8.77e-04 | 18 | 200 | 3 | PS50290 | |
| Domain | CP2 | 1.66e-03 | 6 | 200 | 2 | PF04516 | |
| Domain | CP2 | 1.66e-03 | 6 | 200 | 2 | IPR007604 | |
| Domain | FAT | 1.66e-03 | 6 | 200 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.66e-03 | 6 | 200 | 2 | IPR003151 | |
| Domain | ZF_BBOX | 1.68e-03 | 80 | 200 | 5 | PS50119 | |
| Domain | ZnF_C3H1 | 1.72e-03 | 48 | 200 | 4 | SM00356 | |
| Domain | Znf_B-box | 1.78e-03 | 81 | 200 | 5 | IPR000315 | |
| Domain | zf-CCCH | 1.86e-03 | 49 | 200 | 4 | PF00642 | |
| Domain | WD40 | 1.95e-03 | 259 | 200 | 9 | PF00400 | |
| Domain | WD40 | 2.46e-03 | 268 | 200 | 9 | SM00320 | |
| Domain | ARM-like | 2.59e-03 | 270 | 200 | 9 | IPR011989 | |
| Domain | WD40_repeat | 2.72e-03 | 272 | 200 | 9 | IPR001680 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.13e-20 | 45 | 156 | 16 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L20 PSMD2 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 TADA3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.70e-14 | 191 | 156 | 20 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L20 PSMD2 USP17L19 USP17L18 BRCA1 USP17L17 USP42 USP17L3 USP48 TADA3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.17e-12 | 262 | 156 | 21 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L20 PSMD2 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP48 TADA3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L15 USP17L8 | 4.36e-12 | 221 | 156 | 19 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L20 PSMD2 USP17L19 USP17L18 BRCA1 USP17L17 USP42 USP17L3 USP48 TADA3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 USP17L15 USP17L8 | 1.13e-10 | 299 | 156 | 20 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L20 PSMD2 USP17L19 USP17L18 SPTBN5 PTPN3 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 PPP2R5C USP17L6P USP17L22 USP17L15 USP17L8 | 3.36e-10 | 318 | 156 | 20 | MM15278 |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 3.52e-06 | 22 | 156 | 5 | M9703 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 4.48e-06 | 11 | 156 | 4 | M42562 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 7.25e-06 | 43 | 156 | 6 | M27588 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 8.48e-06 | 26 | 156 | 5 | MM15297 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 1.03e-05 | 27 | 156 | 5 | M27586 | |
| Pathway | PID_FANCONI_PATHWAY | 1.23e-05 | 47 | 156 | 6 | M1 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 1.99e-05 | 51 | 156 | 6 | M29854 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 3.11e-05 | 81 | 156 | 7 | M39490 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 3.86e-05 | 35 | 156 | 5 | MM15293 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 FBXO40 RAD18 RNF168 DCAF8 USP17L20 PSMD2 USP17L19 PGM3 USP17L18 SPTBN5 SAFB POM121 BRCA1 USP17L17 USP42 USP17L3 USP48 TADA3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 CCNF DCAF10 USP17L6P OGFOD1 USP17L22 USP17L15 USP17L8 | 4.56e-05 | 1389 | 156 | 32 | MM15307 |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 4.91e-05 | 19 | 156 | 4 | MM1478 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 5.10e-05 | 37 | 156 | 5 | M27583 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 5.10e-05 | 37 | 156 | 5 | M27568 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 7.15e-05 | 8 | 156 | 3 | M42528 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.22e-04 | 70 | 156 | 6 | M27570 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 FBXO40 RAD18 RNF168 DCAF8 USP17L20 PSMD2 USP17L19 PGM3 USP17L18 SPTBN5 SAFB POM121 BRCA1 USP17L17 USP42 USP17L3 USP48 TADA3 USP17L4 USP17L2 USP17L12 ANK2 USP17L11 USP17L24 USP17L5 CCNF DCAF10 OGFOD1 USP17L22 USP17L15 USP17L8 | 1.43e-04 | 1475 | 156 | 32 | M19806 |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 1.51e-04 | 10 | 156 | 3 | M7239 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.64e-04 | 47 | 156 | 5 | MM15296 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 2.06e-04 | 11 | 156 | 3 | MM1349 | |
| Pathway | WP_HOMOLOGOUS_RECOMBINATION | 2.72e-04 | 12 | 156 | 3 | MM15951 | |
| Pathway | PID_BARD1_PATHWAY | 2.76e-04 | 29 | 156 | 4 | M258 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 3.47e-04 | 55 | 156 | 5 | M39598 | |
| Pathway | WP_HOMOLOGOUS_RECOMBINATION | 3.50e-04 | 13 | 156 | 3 | M39712 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING | 3.50e-04 | 13 | 156 | 3 | M47832 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 3.72e-04 | 120 | 156 | 7 | M40049 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 4.05e-04 | 160 | 156 | 8 | M27498 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 4.81e-04 | 59 | 156 | 5 | MM15283 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 5.43e-04 | 92 | 156 | 6 | M27636 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 5.49e-04 | 15 | 156 | 3 | M47524 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 6.06e-04 | 170 | 156 | 8 | M27582 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 6.09e-04 | 94 | 156 | 6 | M1080 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 6.45e-04 | 36 | 156 | 4 | MM15281 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR | 6.70e-04 | 16 | 156 | 3 | M47855 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 7.20e-04 | 97 | 156 | 6 | M27590 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 9.26e-04 | 68 | 156 | 5 | M27587 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 9.34e-04 | 140 | 156 | 7 | M27584 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.19e-03 | 146 | 156 | 7 | MM15292 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.20e-03 | 72 | 156 | 5 | MM15381 | |
| Pathway | BIOCARTA_ATM_PATHWAY | 1.32e-03 | 20 | 156 | 3 | M10628 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 1.44e-03 | 75 | 156 | 5 | MM15299 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.49e-03 | 291 | 156 | 10 | M16647 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.62e-03 | 154 | 156 | 7 | M39739 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 1.77e-03 | 6 | 156 | 2 | M27585 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 1.77e-03 | 6 | 156 | 2 | MM15295 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 1.78e-03 | 47 | 156 | 4 | M236 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 1.78e-03 | 47 | 156 | 4 | M39518 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.81e-03 | 157 | 156 | 7 | MM15226 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 1.82e-03 | 116 | 156 | 6 | MM15294 | |
| Pathway | WP_INTEGRATED_CANCER_PATHWAY | 1.92e-03 | 48 | 156 | 4 | M39628 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | BRIP1 PHF20 PSMD2 ZNF226 POLR3D POM121 BRCA1 ZNF778 TAF2 TADA3 MRE11 ZFP90 ZNF473 NELFCD MAMLD1 PPP2R5C ZNF28 GTF3A CTCF ZKSCAN3 ZNF221 ATM | 1.98e-03 | 1022 | 156 | 22 | MM15436 |
| Pathway | WP_POSTCOVID_NEUROINFLAMMATION | 2.00e-03 | 23 | 156 | 3 | M48313 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | BRIP1 PHF20 PSMD2 ZNF226 BRCA1 ZNF778 TAF2 MRE11 ZFP90 ZNF473 NELFCD MAMLD1 PPP2R5C ZNF28 CTCF ZKSCAN3 ZNF221 ATM | 2.09e-03 | 768 | 156 | 18 | MM14851 |
| Pathway | REACTOME_MEIOSIS | 2.16e-03 | 120 | 156 | 6 | M529 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.14e-32 | 21 | 204 | 16 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.14e-32 | 21 | 204 | 16 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.14e-32 | 21 | 204 | 16 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.14e-32 | 21 | 204 | 16 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.14e-32 | 21 | 204 | 16 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.14e-32 | 21 | 204 | 16 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 7.80e-32 | 22 | 204 | 16 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 7.61e-31 | 24 | 204 | 16 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.10e-30 | 25 | 204 | 16 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 5.44e-30 | 26 | 204 | 16 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.27e-30 | 33 | 204 | 17 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 15780755 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 9806828 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.25e-29 | 34 | 204 | 17 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.41e-29 | 35 | 204 | 17 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 2.41e-29 | 35 | 204 | 17 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 4.55e-29 | 36 | 204 | 17 | 20147298 | |
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 6.84e-29 | 29 | 204 | 16 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 8.37e-29 | 37 | 204 | 17 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 4.46e-24 | 50 | 204 | 16 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 2.55e-14 | 10 | 204 | 7 | 24207026 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L3 USP17L4 USP17L2 USP17L6P ATM USP17L15 USP17L8 | 8.73e-14 | 19 | 204 | 8 | 28067227 |
| Pubmed | 1.66e-13 | 12 | 204 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 7.14e-13 | 14 | 204 | 7 | 11793228 | |
| Pubmed | 1.15e-09 | 4 | 204 | 4 | 20513533 | ||
| Pubmed | USP17L7 USP42 USP17L3 USP48 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8 | 1.25e-09 | 81 | 204 | 9 | 12838346 | |
| Pubmed | 2.97e-09 | 11 | 204 | 5 | 19584272 | ||
| Pubmed | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 RNF113B USP17L17 USP17L3 WNK3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P KANK4 LY75 USP17L22 USP17L15 USP17L8 | 3.73e-09 | 674 | 204 | 20 | 37196079 | |
| Pubmed | 5.72e-09 | 5 | 204 | 4 | 18642075 | ||
| Pubmed | 2.46e-08 | 31 | 204 | 6 | 19690177 | ||
| Pubmed | 3.67e-08 | 33 | 204 | 6 | 19714462 | ||
| Pubmed | Early mammalian erythropoiesis requires the Dot1L methyltransferase. | 3.97e-08 | 7 | 204 | 4 | 20798234 | |
| Pubmed | 7.90e-08 | 8 | 204 | 4 | 15456891 | ||
| Pubmed | ZC3H13 HMGB1 HMGB2 PGM3 SAFB STRN4 TACC3 WDR77 TNPO1 MRE11 BICRA PHF6 EIF5 PALLD | 1.19e-07 | 399 | 204 | 14 | 35987950 | |
| Pubmed | DOCK4 DCAF8 TRIO ITGA6 MRPS35 MICU1 USP42 STRN4 TAF2 USP48 MMP17 TNPO1 MRE11 TFCP2 ZNF668 GTF3A ZNF335 EIF5 | 1.56e-07 | 689 | 204 | 18 | 36543142 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 15084244 | ||
| Pubmed | A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. | 1.99e-07 | 3 | 204 | 3 | 12773400 | |
| Pubmed | Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. | 1.99e-07 | 3 | 204 | 3 | 11114888 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 12525692 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 34301763 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 24672057 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 19690338 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 24752797 | ||
| Pubmed | Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. | 1.99e-07 | 3 | 204 | 3 | 17333338 | |
| Pubmed | Rapid activation of ATR by ionizing radiation requires ATM and Mre11. | 1.99e-07 | 3 | 204 | 3 | 16431910 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 34517749 | ||
| Pubmed | DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities. | 1.99e-07 | 3 | 204 | 3 | 27317574 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 11278964 | ||
| Pubmed | The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways. | 1.99e-07 | 3 | 204 | 3 | 15279777 | |
| Pubmed | 2.35e-07 | 10 | 204 | 4 | 17478428 | ||
| Pubmed | 2.35e-07 | 10 | 204 | 4 | 37592023 | ||
| Pubmed | Substrate specificities and identification of putative substrates of ATM kinase family members. | 3.19e-07 | 25 | 204 | 5 | 10608806 | |
| Pubmed | 3.66e-07 | 77 | 204 | 7 | 19505873 | ||
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 5.48e-07 | 12 | 204 | 4 | 16391231 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 22072393 | ||
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 7.92e-07 | 4 | 204 | 3 | 23548269 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 7008862 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 17428320 | ||
| Pubmed | 1.49e-06 | 15 | 204 | 4 | 19536649 | ||
| Pubmed | GGNBP2 PHF20 ZC3H13 HMGB1 KDM5D ZNF623 TFCP2L1 CPHXL PLAG1 ZNF473 AIRE PRDM5 TFCP2 ZNF668 GTF3A CTCF ZNF718 ZKSCAN3 | 1.55e-06 | 808 | 204 | 18 | 20412781 | |
| Pubmed | Alternative Functions of Cell Cycle-Related and DNA Repair Proteins in Post-mitotic Neurons. | 1.61e-06 | 61 | 204 | 6 | 34746147 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 19244116 | ||
| Pubmed | The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein. | 1.97e-06 | 5 | 204 | 3 | 2933810 | |
| Pubmed | Direct sequencing of enzymatically amplified human genomic DNA. | 1.97e-06 | 5 | 204 | 3 | 3267215 | |
| Pubmed | A fusion gene in man: DNA sequence analysis of the abnormal globin gene of hemoglobin Miyada. | 1.97e-06 | 5 | 204 | 3 | 6324786 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 3857622 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 2578619 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 2578620 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 7162987 | ||
| Pubmed | mRNA-deficient beta o-thalassemia results from a single nucleotide deletion. | 1.97e-06 | 5 | 204 | 3 | 6292840 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 6292831 | ||
| Pubmed | Unexpected relationships between four large deletions in the human beta-globin gene cluster. | 1.97e-06 | 5 | 204 | 3 | 6652684 | |
| Pubmed | Cloning specific complete polyadenylylated 3'-terminal cDNA segments. | 1.97e-06 | 5 | 204 | 3 | 2581851 | |
| Pubmed | Human beta-globin messenger RNA. I. Nucleotide sequences derived from complementary RNA. | 1.97e-06 | 5 | 204 | 3 | 873928 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 88735 | ||
| Pubmed | BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. | 1.97e-06 | 5 | 204 | 3 | 37549632 | |
| Pubmed | Molecular characterization of seven beta-thalassemia mutations in Asian Indians. | 1.97e-06 | 5 | 204 | 3 | 6714226 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 3455755 | ||
| Pubmed | Human fetal globin DNA sequences suggest novel conversion event. | 1.97e-06 | 5 | 204 | 3 | 6330670 | |
| Pubmed | Beta-thalassemia due to a T----A mutation within the ATA box. | 1.97e-06 | 5 | 204 | 3 | 3382401 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 2444404 | ||
| Pubmed | Nucleotide sequence of the BALB/c mouse beta-globin complex. | 1.97e-06 | 5 | 204 | 3 | 2926808 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 6297279 | ||
| Pubmed | Nonsense and frameshift mutations in beta 0-thalassemia detected in cloned beta-globin genes. | 1.97e-06 | 5 | 204 | 3 | 6985481 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 6985475 | ||
| Pubmed | Identification of a retrovirus-like repetitive element in human DNA. | 1.97e-06 | 5 | 204 | 3 | 6095301 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 21378272 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 6210198 | ||
| Pubmed | Transcriptional interference among the murine beta-like globin genes. | 1.97e-06 | 5 | 204 | 3 | 17077320 | |
| Pubmed | Extensive movement of LINES ONE sequences in beta-globin loci of Mus caroli and Mus domesticus. | 1.97e-06 | 5 | 204 | 3 | 2905421 | |
| Pubmed | An intron nucleotide sequence variant in a cloned beta +-thalassaemia globin gene. | 1.97e-06 | 5 | 204 | 3 | 6264391 | |
| Interaction | RPL23A interactions | MRPS35 HMGB1 HMGB2 PRPF6 SAFB BRCA1 RRP12 WDR77 ATG5 TNPO1 RC3H2 AGR2 RBM28 TFCP2 CCNF ACE2 ZC3H7A ZNF668 CTCF EIF5 DOT1L | 6.01e-07 | 606 | 198 | 21 | int:RPL23A |
| Interaction | POLQ interactions | 2.54e-06 | 23 | 198 | 5 | int:POLQ | |
| Interaction | TRIM28 interactions | RAD18 LRWD1 MYCBP2 ZNF460 MRPS35 HMGB1 PRPF6 ZNF226 PGM3 SAFB BRCA1 BRCA2 ZNF778 ZNF81 USP48 MRE11 RC3H2 ZFP90 CAD ZNF484 ZNF607 ZNF674 AGR2 AIRE CCNF ACE2 ZNF713 ZNF28 ZNF718 TRIM17 EIF5 ATM DOT1L HBE1 | 2.61e-06 | 1474 | 198 | 34 | int:TRIM28 |
| Interaction | SIM2 interactions | 3.94e-06 | 25 | 198 | 5 | int:SIM2 | |
| Interaction | PTGES3 interactions | BRIP1 ZC3H13 BRCA2 DDX60L TASOR CAD AGR2 CASP7 ELP3 WDR19 CCNF ACE2 SMG8 PPP2R5C PTGES3 PACSIN2 | 7.08e-06 | 437 | 198 | 16 | int:PTGES3 |
| Interaction | DNAJA2 interactions | LRWD1 ZNF460 HMGB1 SAFB EML5 BRCA1 SACS USP48 TNPO1 TRAF7 RC3H2 CAD AGR2 ELP3 WDR19 CCNF DCAF10 CTSH | 7.17e-06 | 542 | 198 | 18 | int:DNAJA2 |
| Interaction | POLN interactions | 1.41e-05 | 32 | 198 | 5 | int:POLN | |
| Interaction | FLT3 interactions | USP17L21 USP17L20 USP17L19 USP17L18 BRCA1 BRCA2 USP17L17 RRP12 USP17L12 USP17L11 PHF6 RBM28 TNPO3 | 1.67e-05 | 318 | 198 | 13 | int:FLT3 |
| Interaction | TFAP4 interactions | 2.10e-05 | 153 | 198 | 9 | int:TFAP4 | |
| Interaction | POLR1G interactions | HMGB1 HMGB2 FASTKD5 PRPF6 PRDM2 SPTBN5 POLR3D RRP12 TAF2 USP48 TADA3 RC3H2 BICRA RBM28 CTCF DOT1L | 2.82e-05 | 489 | 198 | 16 | int:POLR1G |
| Interaction | RPL10A interactions | RAD18 HMGB1 HMGB2 PRPF6 BRCA1 USP48 RC3H2 AGR2 PRDM5 TFCP2 CCNF ACE2 ZNF668 CTCF EIF5 DOT1L | 2.89e-05 | 490 | 198 | 16 | int:RPL10A |
| Interaction | PARP1 interactions | RAD18 RNF168 MYCBP2 HMGB1 PSMD2 HMGB2 PRPF6 PGM3 PRDM2 BRCA1 BRCA2 SACS RRP12 USP48 TNPO1 MRE11 BICRA AGR2 PHF6 AIRE CASP7 RBM28 TFCP2 CCNF ACE2 CTCF ATM TDP1 TNPO3 | 3.65e-05 | 1316 | 198 | 29 | int:PARP1 |
| Interaction | RPSA interactions | ITGA6 HMGB1 HMGB2 BRCA1 RRP12 USP48 WDR77 RC3H2 EPB41L5 TFCP2 CCNF ACE2 CTCF ZNF335 EIF5 HBG2 | 6.14e-05 | 522 | 198 | 16 | int:RPSA |
| Interaction | DCLRE1C interactions | 6.19e-05 | 43 | 198 | 5 | int:DCLRE1C | |
| Interaction | RPS19 interactions | GIN1 HMGB1 HMGB2 BRCA1 RRP12 TAF2 USP48 TNPO1 RC3H2 ZFP90 EPB41L5 RBM28 TFCP2 CCNF ACE2 ZNF668 CTCF EIF5 | 6.31e-05 | 639 | 198 | 18 | int:RPS19 |
| Interaction | RPS18 interactions | HMGB1 HMGB2 BRCA1 USP48 TASOR WDR77 RC3H2 PHF6 TFCP2 CCNF ACE2 CTCF EIF5 DOT1L | 6.52e-05 | 415 | 198 | 14 | int:RPS18 |
| Interaction | PRNP interactions | DOCK4 DCAF8 TRIO ITGA6 MRPS35 HMGB1 PSMD2 PGM3 MICU1 USP42 CYB5R3 STRN4 TAF2 USP48 MMP17 TNPO1 MRE11 ANK2 TFCP2 ACE2 ZNF668 GTF3A ZNF335 EIF5 PRKD1 PACSIN2 | 7.08e-05 | 1158 | 198 | 26 | int:PRNP |
| Interaction | RPS14 interactions | GIN1 HMGB1 BRCA1 RRP12 USP48 WDR77 RC3H2 NELFCD AGR2 RBM28 TFCP2 CCNF ACE2 DCAF10 CTCF EIF5 | 7.18e-05 | 529 | 198 | 16 | int:RPS14 |
| Interaction | RPS28 interactions | GIN1 HMGB1 HMGB2 TASOR WDR77 RC3H2 TFCP2 CCNF ACE2 CTCF EIF5 DOT1L | 7.20e-05 | 316 | 198 | 12 | int:RPS28 |
| Interaction | ZNF326 interactions | 7.74e-05 | 224 | 198 | 10 | int:ZNF326 | |
| Interaction | RPL11 interactions | HMGB1 HMGB2 BRCA1 USP42 USP48 TNPO1 RC3H2 AGR2 EPB41L5 RBM28 TFCP2 CCNF ACE2 ZNF668 CTCF EIF5 ATM DOT1L | 8.15e-05 | 652 | 198 | 18 | int:RPL11 |
| Interaction | NBN interactions | 8.49e-05 | 183 | 198 | 9 | int:NBN | |
| Interaction | RPS21 interactions | PSMD2 HMGB2 RC3H2 PHF6 CCNF ACE2 PPP2R5C CTCF EIF5 PRKD1 DOT1L | 9.73e-05 | 277 | 198 | 11 | int:RPS21 |
| Interaction | GAR1 interactions | 1.04e-04 | 232 | 198 | 10 | int:GAR1 | |
| Interaction | SMARCC1 interactions | RAD18 SAMD9 MYCBP2 TFCP2L1 BRCA1 TNPO1 MRE11 RC3H2 TRIM42 BICRA SIX1 CCNF TNPO3 | 1.15e-04 | 384 | 198 | 13 | int:SMARCC1 |
| Interaction | ZCCHC10 interactions | ZNF460 MICU1 PTPN3 USP42 DDX60L TAF2 USP48 BICRA EPB41L5 TFCP2 | 1.19e-04 | 236 | 198 | 10 | int:ZCCHC10 |
| Interaction | RPL31 interactions | RAD18 DCAF8 ZC3H13 HMGB1 HMGB2 PRPF6 BRCA1 RRP12 RC3H2 AGR2 EPB41L5 RBM28 TFCP2 CCNF ACE2 ZNF668 CTCF EIF5 | 1.38e-04 | 680 | 198 | 18 | int:RPL31 |
| Interaction | RPS25 interactions | HMGB1 HMGB2 BRCA1 WDR77 RC3H2 AGR2 PHF6 TFCP2 CCNF ACE2 CTCF EIF5 DOT1L | 1.41e-04 | 392 | 198 | 13 | int:RPS25 |
| Interaction | ZFAT interactions | 1.54e-04 | 28 | 198 | 4 | int:ZFAT | |
| Interaction | PARG interactions | 1.54e-04 | 28 | 198 | 4 | int:PARG | |
| Interaction | RPL18 interactions | MRPS35 HMGB1 BRCA1 STRN4 RC3H2 AGR2 RBM28 TFCP2 CCNF ACE2 ZNF668 CTCF PRKD1 DOT1L PTGES3 | 1.71e-04 | 512 | 198 | 15 | int:RPL18 |
| Interaction | DNAJC9 interactions | RAD18 DCAF8 ZC3H13 PRPF6 RRP12 TADA3 RC3H2 RBM28 ACE2 CTCF DOT1L | 1.74e-04 | 296 | 198 | 11 | int:DNAJC9 |
| Interaction | DTL interactions | 1.76e-04 | 119 | 198 | 7 | int:DTL | |
| Interaction | RNF135 interactions | 1.77e-04 | 29 | 198 | 4 | int:RNF135 | |
| Interaction | PRKDC interactions | RAD18 ATR HMGB1 HMGB2 TFCP2L1 BRCA1 MRE11 AGR2 AIRE TFCP2 CCNF ACE2 ZC3H7A CTCF EIF5 ATM DOT1L PTGES3 | 1.81e-04 | 695 | 198 | 18 | int:PRKDC |
| Interaction | ZNF710 interactions | 2.03e-04 | 30 | 198 | 4 | int:ZNF710 | |
| Interaction | TKT interactions | BRCA1 CYB5R3 USP48 MAP3K19 ATG5 AGR2 TFCP2 WDR19 CCNF ACE2 SMG8 PTGES3 | 2.03e-04 | 353 | 198 | 12 | int:TKT |
| Interaction | SLC1A5 interactions | INSIG1 MRPS35 PTPN3 CYB5R3 RC3H2 AGR2 TFCP2 CCNF ACE2 ZC3H7A | 2.03e-04 | 252 | 198 | 10 | int:SLC1A5 |
| Interaction | UPF1 interactions | SMG1 ATR MYCBP2 BRCA1 BRCA2 USP48 RC3H2 AGR2 PRDM5 CCNF ACE2 ZC3H7A SMG8 PRKD1 ATM DOT1L | 2.10e-04 | 581 | 198 | 16 | int:UPF1 |
| Interaction | EIF3A interactions | ZC3H13 HMGB2 PTPN3 BRCA1 WNK3 AGR2 TFCP2 CCNF ACE2 CTCF EIF5 DOT1L | 2.14e-04 | 355 | 198 | 12 | int:EIF3A |
| Interaction | EIF4A1 interactions | MYCBP2 TAF2 WDR77 RC3H2 AGR2 TFCP2 CCNF ACE2 ZC3H7A CTCF EIF5 DOT1L | 2.14e-04 | 355 | 198 | 12 | int:EIF4A1 |
| Interaction | RPS7 interactions | SMG1 HMGB2 BRCA1 CYB5R3 TNPO1 RC3H2 AGR2 TEX15 TFCP2 CCNF ACE2 CTCF EIF5 DOT1L | 2.19e-04 | 466 | 198 | 14 | int:RPS7 |
| Interaction | MAGEA9 interactions | 2.23e-04 | 208 | 198 | 9 | int:MAGEA9 | |
| Interaction | MYL6 interactions | 2.23e-04 | 255 | 198 | 10 | int:MYL6 | |
| Interaction | PRSS3 interactions | 2.41e-04 | 57 | 198 | 5 | int:PRSS3 | |
| Interaction | SRPK2 interactions | RAD18 ZNF234 MYCBP2 ZC3H13 PTPN22 PRPF6 SAFB RRP12 ENOX2 ATG5 PHF6 RBM28 CCNF ZNF668 DCAF10 CTCF DOT1L PALLD | 2.64e-04 | 717 | 198 | 18 | int:SRPK2 |
| Interaction | SMC1A interactions | ATR PRPF6 BRCA1 BRCA2 MTUS1 MRE11 AIRE SIX1 CCNF ACE2 CTCF ATM DOT1L | 2.64e-04 | 418 | 198 | 13 | int:SMC1A |
| Interaction | RPS3A interactions | HMGB1 HMGB2 BRCA1 RRP12 USP48 WDR77 TNPO1 RC3H2 GIT1 RBM28 TFCP2 CCNF ACE2 ZNF668 CTCF EIF5 TNPO3 | 2.67e-04 | 655 | 198 | 17 | int:RPS3A |
| Interaction | SRP14 interactions | RAD18 MRPS35 HMGB1 RRP12 USP48 RC3H2 PHF6 RBM28 CCNF ACE2 ZNF668 NISCH | 2.82e-04 | 366 | 198 | 12 | int:SRP14 |
| Interaction | GIGYF2 interactions | 2.86e-04 | 263 | 198 | 10 | int:GIGYF2 | |
| Interaction | EIF3E interactions | 2.86e-04 | 263 | 198 | 10 | int:EIF3E | |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 | 1.69e-15 | 79 | 204 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 TACC3 USP17L12 USP17L11 USP17L24 USP17L5 RGS12 ZNF718 USP17L6P USP17L22 USP17L15 | 1.02e-13 | 222 | 204 | 15 | chr4p16 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF234 ZNF460 ZNF226 ZNF623 ZNF778 PLAG1 ZNF578 ZNF81 ZFP90 ZNF473 ZNF484 ZNF607 ZNF674 PRDM5 ZNF404 ZNF668 ZNF630 ZNF713 ZNF28 ZSCAN10 GTF3A CTCF ZNF718 ZNF425 ZNF335 ZKSCAN3 ZNF221 ZNF415 | 2.02e-12 | 718 | 143 | 28 | 28 |
| GeneFamily | Ring finger proteins | RAD18 RNF168 TRIM34 RNF113B BRCA1 MGRN1 TRAF7 RC3H2 TRIM42 RFPL4B TRIM9 TRIM17 | 1.96e-06 | 275 | 143 | 12 | 58 |
| GeneFamily | Hemoglobin subunits | 5.58e-05 | 10 | 143 | 3 | 940 | |
| GeneFamily | WD repeat domain containing | 2.42e-04 | 262 | 143 | 9 | 362 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 3.69e-04 | 4 | 143 | 2 | 1335 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.00e-04 | 20 | 143 | 3 | 548 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 6.12e-04 | 5 | 143 | 2 | 1336 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 7.03e-04 | 51 | 143 | 4 | 870 | |
| GeneFamily | Zinc fingers CCCH-type | 2.63e-03 | 35 | 143 | 3 | 73 | |
| GeneFamily | Ankyrin repeat domain containing | 3.16e-03 | 242 | 143 | 7 | 403 | |
| GeneFamily | Canonical high mobility group | 3.26e-03 | 11 | 143 | 2 | 511 | |
| GeneFamily | Ribonuclease A family | 4.58e-03 | 13 | 143 | 2 | 723 | |
| GeneFamily | PHD finger proteins | 5.67e-03 | 90 | 143 | 4 | 88 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 6.10e-03 | 15 | 143 | 2 | 696 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 6.85e-03 | 95 | 143 | 4 | 59 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 7.82e-03 | 17 | 143 | 2 | 1197 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 8.75e-03 | 18 | 143 | 2 | 812 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 8.75e-03 | 18 | 143 | 2 | 498 | |
| GeneFamily | Armadillo repeat containing|Importins | 8.75e-03 | 18 | 143 | 2 | 596 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 5.53e-18 | 86 | 203 | 16 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 NISCH USP17L6P USP17L22 USP17L15 USP17L8 | 1.86e-17 | 112 | 203 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L20 USP17L19 RRAD USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 8.60e-15 | 160 | 203 | 17 | MM1155 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 GGNBP2 CENPL USP17L20 INSIG1 PTPN22 USP17L19 F2RL2 USP17L18 BRCA1 USP17L17 RRP12 USP17L3 USP48 TNPO1 USP17L4 CAD USP17L2 USP17L12 USP17L11 USP17L5 LRRC8D TRIM17 EIF5 USP17L6P ATM USP17L22 USP17L15 USP17L8 | 1.13e-09 | 1072 | 203 | 30 | MM1031 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L20 ITGA6 USP17L19 USP17L18 TFCP2L1 POM121 USP17L17 USP17L3 TACC3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 1.73e-07 | 647 | 203 | 20 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 DDX59 USP17L20 PTPN22 USP17L19 RRAD USP17L18 TFCP2L1 USP17L17 GCLM USP17L3 ZNF778 DSCC1 TADA3 MRE11 USP17L4 USP17L2 USP17L12 USP17L11 PHF6 USP17L5 LRRC8D USP17L6P USP17L22 USP17L15 PACSIN2 USP17L8 | 1.91e-07 | 1198 | 203 | 28 | MM1062 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 6.86e-06 | 168 | 203 | 9 | M18811 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 GGNBP2 LRWD1 USP17L20 ITGA6 TRIM34 USP17L19 USP17L18 TFCP2L1 POLR3D POM121 USP17L17 USP17L3 TACC3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 TRIM17 USP17L6P USP17L22 USP17L15 USP17L8 | 1.01e-05 | 1226 | 203 | 25 | MM979 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DOCK4 SMG1 HAUS6 RAD18 BRIP1 ZNF234 ATR CENPL HMGB2 POGLUT1 BRCA1 BRCA2 SACS ANKIB1 ZNF81 DDX60L DSCC1 TNPO1 CAD ZNF473 RBM28 ELP3 TFCP2 CCNF ZNF718 TET1 ZKSCAN3 | 1.29e-05 | 1407 | 203 | 27 | M14427 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.33e-05 | 230 | 203 | 10 | M11563 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HAUS6 GGNBP2 RAD18 CTNNAL1 ATR MYCBP2 ITGA6 HMGB1 BRCA1 MTUS1 SACS USP48 TASOR ENOX2 TNPO1 ATM PALLD | 1.54e-05 | 656 | 203 | 17 | M18979 |
| Coexpression | HEVNER_TELENCEPHALON_ERYTHROCYTES | 2.49e-05 | 8 | 203 | 3 | MM389 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP | 2.76e-05 | 200 | 203 | 9 | M4790 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | PHF20 ATR INSIG1 HMGB2 PTPN22 BRCA1 BRCA2 WDR77 MRE11 CAD CCNF PPP2R5C CTCF | 3.05e-05 | 426 | 203 | 13 | M9516 |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 3.84e-05 | 118 | 203 | 7 | M15305 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | RNF168 PRPF6 KLHL32 SAFB EML5 BRCA1 BRCA2 MAP3K19 SLC4A8 MAMLD1 LRRC8D | 9.64e-07 | 192 | 184 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | HAUS6 RAD18 DDX59 RNF168 PHF20 ATR GIN1 ZC3H13 INSIG1 HMGB2 FASTKD5 PRPF6 TLR7 EML5 BRCA1 BRCA2 USP42 DSCC1 WNK3 SLC4A8 ANK2 AGR2 VEPH1 PHF6 TET1 EIF5 ATM | 1.18e-05 | 1257 | 184 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RAD18 DDX59 RNF168 NAA60 GIN1 PRPF6 ZNF226 BRCA1 BRCA2 STRN4 ANKIB1 USP48 SLC4A8 WDR19 ZC3H7A PPP2R5C GTF3A TET1 ZKSCAN3 GABBR1 | 1.52e-05 | 780 | 184 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | HAUS6 RAD18 BRIP1 CENPL KLHL32 PTPN3 BRCA1 DSCC1 WDR77 CAD RNASE12 LY75 | 2.13e-05 | 316 | 184 | 12 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | HAUS6 RAD18 DDX59 RNF168 PHF20 ATR GIN1 ZC3H13 INSIG1 HMGB2 FASTKD5 PRPF6 TLR7 EML5 BRCA1 BRCA2 USP42 DSCC1 WNK3 SLC4A8 ANK2 AGR2 VEPH1 PHF6 AIRE TET1 EIF5 ATM HBG2 | 2.31e-05 | 1459 | 184 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RNF168 GIN1 HMGB2 KLHL32 SAFB EML5 BRCA1 MAMLD1 EPB41L5 LRRC8D WDR19 EIF5 | 3.08e-05 | 328 | 184 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SMG1 RAD18 BRIP1 PDE8A ATR GIN1 PSMD2 TRANK1 EML5 BRCA1 BRCA2 GCLM DSCC1 WNK3 MRE11 CAD TEX15 PPP2R5C TET1 ATM | 3.09e-05 | 820 | 184 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_200 | 3.47e-05 | 8 | 184 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RNF168 GIN1 PRPF6 KLHL32 SAFB EML5 BRCA1 BRCA2 STRN4 ANKIB1 USP48 MAP3K19 SLC4A8 MAMLD1 EPB41L5 LRRC8D WDR19 PPP2R5C TRIM9 GABBR1 | 3.73e-05 | 831 | 184 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RNF168 VWA8 GIN1 INSIG1 HMGB2 KLHL32 SAFB EML5 BRCA1 MTUS1 SLC4A8 MAMLD1 EPB41L5 LRRC8D WDR19 TRIM9 EIF5 | 5.78e-05 | 654 | 184 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SMG1 RNF168 PHF20 TRIO HMGB1 PRPF6 PRDM2 EML5 USP42 DSCC1 TASOR WNK3 MAMLD1 EPB41L5 SMG8 CTCF | 6.47e-05 | 595 | 184 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_100 | 7.47e-05 | 2 | 184 | 2 | gudmap_developingKidney_e12.5_renal vesicle_100_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | RAD18 BRIP1 ATR GIN1 PSMD2 BRCA1 BRCA2 GCLM DSCC1 MRE11 CAD ATM | 7.73e-05 | 361 | 184 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | RAD18 BRIP1 PHF20 ATR GIN1 PSMD2 PTPN3 EML5 BRCA1 BRCA2 GCLM RRP12 WDR77 ATG5 CAD TEX15 PPP2R5C TET1 ATM | 8.27e-05 | 810 | 184 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RNF168 GIN1 PRPF6 SAFB BRCA1 BRCA2 ANKIB1 MAP3K19 SLC4A8 LRRC8D WDR19 | 8.93e-05 | 311 | 184 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RNF168 PRPF6 KLHL32 SAFB EML5 BRCA1 BRCA2 MAP3K19 SLC4A8 MAMLD1 SHH EPB41L5 LRRC8D TRIM9 | 1.18e-04 | 498 | 184 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HAUS6 RNF168 TRIO MYCBP2 ZC3H13 HMGB1 PRPF6 USP42 DSCC1 TASOR DLGAP4 PHF6 SMG8 GTF3A EIF5 | 1.24e-04 | 564 | 184 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DOCK4 SMG1 GGNBP2 RAD18 ATR ZC3H13 ITGA6 EML5 BRCA1 BRCA2 SACS RC3H2 ZNF473 TEX15 NISCH ZKSCAN3 ATM HBE1 | 1.47e-04 | 776 | 184 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | DOCK4 ZCCHC24 RAD18 BRIP1 KDM5D KLHL32 TRANK1 PLAG1 DSCC1 VEGFD WNK3 MAMLD1 PRDM5 ACE2 KANK4 PRKD1 HBE1 PALLD | 1.92e-04 | 793 | 184 | 18 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.99e-04 | 232 | 184 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RAD18 BRIP1 ATR PTPN3 TFCP2L1 BRCA1 BRCA2 GCLM USP48 ATG5 MRE11 CAD ZNF473 TEX15 CCNF TET1 ATM HBE1 | 2.11e-04 | 799 | 184 | 18 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | ZCCHC24 SMG1 GGNBP2 PHF20 ZC3H13 RC3H2 ACE2 TRIM9 NISCH TET1 ZKSCAN3 HBE1 | 2.70e-04 | 413 | 184 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.78e-04 | 192 | 184 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.93e-04 | 104 | 184 | 6 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | GIN1 PRPF6 FNDC1 BRCA2 VEGFD MAP3K19 LRRC8D WDR19 ZSCAN10 GTF3A HBG1 CTSH HBG2 | 3.76e-04 | 492 | 184 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-06 | 180 | 197 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.63e-06 | 183 | 197 | 8 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.99e-06 | 188 | 197 | 8 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 195 | 197 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 196 | 197 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.15e-06 | 200 | 197 | 8 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.15e-06 | 200 | 197 | 8 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.15e-06 | 200 | 197 | 8 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | 3.15e-06 | 200 | 197 | 8 | 093e97395be23092229521cc55aaaee8befbc149 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 169 | 197 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 172 | 197 | 7 | 6379ae0aca9007c3a8a87e3330908fc90961ad3f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 1.22e-05 | 173 | 197 | 7 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.47e-05 | 178 | 197 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 189 | 197 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 192 | 197 | 7 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 2.47e-05 | 193 | 197 | 7 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-05 | 194 | 197 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 194 | 197 | 7 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.56e-05 | 194 | 197 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-05 | 194 | 197 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-05 | 194 | 197 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-05 | 194 | 197 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 195 | 197 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 195 | 197 | 7 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.73e-05 | 196 | 197 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 197 | 197 | 7 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 198 | 197 | 7 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 198 | 197 | 7 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.01e-05 | 199 | 197 | 7 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 3.01e-05 | 199 | 197 | 7 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 3.01e-05 | 199 | 197 | 7 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.01e-05 | 199 | 197 | 7 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 200 | 197 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 3.11e-05 | 200 | 197 | 7 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 200 | 197 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 200 | 197 | 7 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.11e-05 | 200 | 197 | 7 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.11e-05 | 200 | 197 | 7 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 200 | 197 | 7 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.11e-05 | 200 | 197 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 3.11e-05 | 200 | 197 | 7 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.11e-05 | 200 | 197 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 3.11e-05 | 200 | 197 | 7 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 3.11e-05 | 200 | 197 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.11e-05 | 200 | 197 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.11e-05 | 200 | 197 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.11e-05 | 200 | 197 | 7 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-05 | 163 | 197 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 9.37e-05 | 165 | 197 | 6 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.69e-05 | 166 | 197 | 6 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 167 | 197 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 167 | 197 | 6 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 167 | 197 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.03e-04 | 168 | 197 | 6 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 168 | 197 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 168 | 197 | 6 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 168 | 197 | 6 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 169 | 197 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 169 | 197 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 169 | 197 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-04 | 170 | 197 | 6 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.18e-04 | 108 | 197 | 5 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 174 | 197 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 174 | 197 | 6 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 174 | 197 | 6 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 175 | 197 | 6 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 176 | 197 | 6 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 176 | 197 | 6 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 177 | 197 | 6 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 177 | 197 | 6 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 177 | 197 | 6 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 1.42e-04 | 178 | 197 | 6 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.55e-04 | 181 | 197 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.55e-04 | 181 | 197 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.60e-04 | 182 | 197 | 6 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.65e-04 | 183 | 197 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 184 | 197 | 6 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 184 | 197 | 6 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.75e-04 | 185 | 197 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-04 | 185 | 197 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 185 | 197 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 197 | 6 | 969248b63d4ce335f223528de756bcddffadbd77 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 185 | 197 | 6 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.80e-04 | 186 | 197 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 187 | 197 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 187 | 197 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 187 | 197 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 188 | 197 | 6 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 1.91e-04 | 188 | 197 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 188 | 197 | 6 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 189 | 197 | 6 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.96e-04 | 189 | 197 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 2.02e-04 | 190 | 197 | 6 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-04 | 190 | 197 | 6 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-04 | 190 | 197 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-04 | 190 | 197 | 6 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 190 | 197 | 6 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-04 | 190 | 197 | 6 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| Drug | DB07883 | 2.21e-07 | 75 | 191 | 8 | CID000446476 | |
| Drug | veliparib | 9.25e-07 | 22 | 191 | 5 | ctd:C521013 | |
| Drug | zinc chromate | 3.23e-06 | 13 | 191 | 4 | ctd:C023616 | |
| Drug | CPG-oligonucleotide | 3.69e-06 | 184 | 191 | 10 | ctd:C408982 | |
| Drug | nitrendipine; Down 200; 10uM; MCF7; HG-U133A | 7.07e-06 | 198 | 191 | 10 | 336_DN | |
| Drug | Camptothecin | 1.00e-05 | 163 | 191 | 9 | ctd:D002166 | |
| Drug | pentoxifylline | PDE8A ITGA6 BRCA1 NELFCD ALPK1 TFCP2 RGS12 NISCH TDP1 HBE1 HBG1 HBG2 | 1.07e-05 | 304 | 191 | 12 | CID000004740 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 7.52e-28 | 46 | 197 | 18 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP42 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L8 | 4.03e-24 | 69 | 197 | 18 | DOID:1682 (implicated_via_orthology) |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.83e-06 | 14 | 197 | 4 | C0677776 | |
| Disease | Malignant neoplasm of ovary | 4.10e-06 | 137 | 197 | 8 | C1140680 | |
| Disease | breast carcinoma (is_marker_for) | 5.34e-06 | 66 | 197 | 6 | DOID:3459 (is_marker_for) | |
| Disease | BREAST CANCER | 1.06e-05 | 21 | 197 | 4 | 114480 | |
| Disease | breast cancer (implicated_via_orthology) | 2.18e-05 | 25 | 197 | 4 | DOID:1612 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 2.39e-05 | 9 | 197 | 3 | C2931038 | |
| Disease | Malignant tumor of breast | 3.00e-05 | 27 | 197 | 4 | cv:C0006142 | |
| Disease | Breast neoplasm | 3.00e-05 | 27 | 197 | 4 | cv:C1458155 | |
| Disease | Familial cancer of breast | 3.00e-05 | 27 | 197 | 4 | cv:C0346153 | |
| Disease | rheumatoid arthritis, systemic lupus erythematosus | 3.40e-05 | 10 | 197 | 3 | EFO_0000685, MONDO_0007915 | |
| Disease | ovarian neoplasm | 3.41e-05 | 134 | 197 | 7 | C0919267 | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 4.43e-05 | 2 | 197 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 4.43e-05 | 2 | 197 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 4.43e-05 | 2 | 197 | 2 | C4749652 | |
| Disease | Breast Cancer, Familial | 4.61e-05 | 30 | 197 | 4 | C0346153 | |
| Disease | colon cancer (is_implicated_in) | 9.60e-05 | 36 | 197 | 4 | DOID:219 (is_implicated_in) | |
| Disease | Hemoglobin F Disease | 1.26e-04 | 15 | 197 | 3 | C0019025 | |
| Disease | FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 | 1.32e-04 | 3 | 197 | 2 | 141749 | |
| Disease | Hereditary persistence of fetal hemoglobin | 1.32e-04 | 3 | 197 | 2 | cv:C0019025 | |
| Disease | delta beta-thalassemia (is_implicated_in) | 1.32e-04 | 3 | 197 | 2 | DOID:0080773 (is_implicated_in) | |
| Disease | Inherited neuropathies | 1.46e-04 | 40 | 197 | 4 | C0598589 | |
| Disease | Hereditary breast ovarian cancer syndrome | 2.64e-04 | 4 | 197 | 2 | cv:C0677776 | |
| Disease | hemoglobin measurement, fetal hemoglobin measurement | 2.64e-04 | 4 | 197 | 2 | EFO_0004509, EFO_0004576 | |
| Disease | FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 | 2.64e-04 | 4 | 197 | 2 | C1841621 | |
| Disease | Adenocarcinoma of prostate | 3.07e-04 | 20 | 197 | 3 | C0007112 | |
| Disease | fetal hemoglobin measurement | 3.57e-04 | 21 | 197 | 3 | EFO_0004576 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 4.38e-04 | 5 | 197 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | breast cancer (is_implicated_in) | 5.29e-04 | 150 | 197 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | Fanconi Anemia | 6.05e-04 | 25 | 197 | 3 | C0015625 | |
| Disease | Adult only | 6.54e-04 | 6 | 197 | 2 | C3842001 | |
| Disease | ovarian carcinoma (is_marker_for) | 8.49e-04 | 28 | 197 | 3 | DOID:4001 (is_marker_for) | |
| Disease | Mammary Neoplasms | BRIP1 RRAD BRCA1 BRCA2 AGR2 CASP7 ELP3 ZNF404 CTCF NISCH ATM | 8.85e-04 | 527 | 197 | 11 | C1458155 |
| Disease | Intellectual Disability | 8.98e-04 | 447 | 197 | 10 | C3714756 | |
| Disease | blood sedimentation | 9.11e-04 | 7 | 197 | 2 | EFO_0004304 | |
| Disease | infertility (implicated_via_orthology) | 9.11e-04 | 7 | 197 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | DDX59 BRIP1 RRAD BRCA1 BRCA2 MRE11 ANK2 AGR2 CASP7 ELP3 ZNF404 ZNF668 NISCH EIF5 FAM217B ATM FCRL5 | 9.22e-04 | 1074 | 197 | 17 | C0006142 |
| Disease | Miller Dieker syndrome | 9.42e-04 | 29 | 197 | 3 | C0265219 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 9.42e-04 | 29 | 197 | 3 | C0496920 | |
| Disease | pancreatic cancer (is_implicated_in) | 9.49e-04 | 112 | 197 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | mean reticulocyte volume | BRIP1 SAMD9 RNF168 ATR HMGB1 SAFB TACC3 PREX1 TNPO1 CAD ATM LY75 HBE1 HBG2 | 1.01e-03 | 799 | 197 | 14 | EFO_0010701 |
| Disease | Ovarian Carcinoma | 1.04e-03 | 30 | 197 | 3 | C0029925 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.06e-03 | 67 | 197 | 4 | C3463824 | |
| Disease | Prostate cancer, familial | 1.19e-03 | 69 | 197 | 4 | C2931456 | |
| Disease | sickle cell anemia | 1.21e-03 | 8 | 197 | 2 | MONDO_0011382 | |
| Disease | female breast cancer (is_implicated_in) | 1.21e-03 | 8 | 197 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Hyperkinesia | 1.26e-03 | 32 | 197 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 1.26e-03 | 32 | 197 | 3 | C0751217 | |
| Disease | breast cancer (is_marker_for) | 1.57e-03 | 185 | 197 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Malignant Neoplasms | 1.72e-03 | 128 | 197 | 5 | C0006826 | |
| Disease | Nephroblastoma | 1.78e-03 | 36 | 197 | 3 | C0027708 | |
| Disease | endometrial cancer (is_implicated_in) | 1.78e-03 | 36 | 197 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | ankyrin-2 measurement | 1.93e-03 | 10 | 197 | 2 | EFO_0021874 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.93e-03 | 10 | 197 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | colorectal carcinoma (is_marker_for) | 1.93e-03 | 37 | 197 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 2.08e-03 | 38 | 197 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.25e-03 | 82 | 197 | 4 | EFO_0005658 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 2.34e-03 | 11 | 197 | 2 | EFO_0801871 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.59e-03 | 41 | 197 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.59e-03 | 41 | 197 | 3 | C0858252 | |
| Disease | basal cell carcinoma (is_implicated_in) | 2.80e-03 | 12 | 197 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 2.92e-03 | 525 | 197 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.92e-03 | 525 | 197 | 10 | C1257931 | |
| Disease | Thromboembolism | 3.17e-03 | 44 | 197 | 3 | HP_0001907 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 3.30e-03 | 13 | 197 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Benign tumor of pancreas | 3.30e-03 | 13 | 197 | 2 | C0347284 | |
| Disease | Genetic chronic primary adrenal insufficiency | 3.30e-03 | 13 | 197 | 2 | Orphanet_101960 | |
| Disease | hematocrit | TMCC3 TFCP2L1 CYB5R3 TASOR MAP3K19 MGRN1 MAMLD1 EPB41L5 PHF6 RNASE12 TH DOT1L HBE1 HBG1 HBG2 | 3.38e-03 | 1011 | 197 | 15 | EFO_0004348 |
| Disease | Breast Carcinoma | 3.47e-03 | 538 | 197 | 10 | C0678222 | |
| Disease | dimethylglycine measurement | 3.60e-03 | 46 | 197 | 3 | EFO_0010476 | |
| Disease | mean platelet volume | HAUS6 PHF20 ITGA6 PSMD2 TRANK1 CYB5R3 ZNF778 TASOR TNPO1 NELFCD LRRC8D RGS12 LY75 PTGES3 PACSIN2 | 3.67e-03 | 1020 | 197 | 15 | EFO_0004584 |
| Disease | skin melanoma (is_implicated_in) | 3.83e-03 | 14 | 197 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | nephroblastoma (is_implicated_in) | 3.83e-03 | 14 | 197 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Fanconi anemia | 3.83e-03 | 14 | 197 | 2 | cv:C0015625 | |
| Disease | colorectal cancer (is_marker_for) | 4.15e-03 | 157 | 197 | 5 | DOID:9256 (is_marker_for) | |
| Disease | alpha fetoprotein measurement | 4.59e-03 | 100 | 197 | 4 | EFO_0010583 | |
| Disease | Pancreatic Neoplasm | 4.59e-03 | 100 | 197 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 4.92e-03 | 102 | 197 | 4 | C0346647 | |
| Disease | sickle cell anemia (is_implicated_in) | 5.00e-03 | 16 | 197 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | interleukin 1 receptor antagonist measurement | 5.37e-03 | 53 | 197 | 3 | EFO_0004754 | |
| Disease | Benign neoplasm of stomach | 5.65e-03 | 17 | 197 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.65e-03 | 17 | 197 | 2 | C0496905 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 5.65e-03 | 17 | 197 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 5.65e-03 | 17 | 197 | 2 | C0154060 | |
| Disease | Leukemia, Myelocytic, Acute | 6.23e-03 | 173 | 197 | 5 | C0023467 | |
| Disease | Bone marrow hypocellularity | 6.32e-03 | 18 | 197 | 2 | C1855710 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FHDFKSVDHLKVCPR | 11 | O75528 | |
| HHLDECPHSQALKKV | 76 | O95994 | |
| NHLCGADFVKSHQKP | 246 | O95394 | |
| SEHTVDSKCFPAELH | 141 | Q9Y2D0 | |
| ILQKHTENVAKFHCP | 426 | P49711 | |
| LRKKCPSTHSEELHD | 31 | P48507 | |
| QDPHTKKALEAHCRA | 501 | Q13362 | |
| PCDCAEKQHHKDLAL | 181 | Q9P2G1 | |
| FKHDSFVPCSEKIHL | 666 | Q9Y2X7 | |
| HLELDCTKFSLPHLS | 691 | Q8TEK3 | |
| TVHFKSFPEKDLLHC | 101 | Q9H1Y0 | |
| DLLHCPSKDAIEAHF | 111 | Q9H1Y0 | |
| HAHEVCQKTSATLDK | 301 | Q9Y2H0 | |
| TLHLKEKEGCPQAFH | 46 | O43918 | |
| FDHHLLSAAEACKLA | 271 | Q96QP1 | |
| FDENVHKPISLGCSH | 21 | Q9HBD1 | |
| IVLHPDTEHSKGCAF | 366 | Q9NW13 | |
| KDPDDHTVCHLLFAN | 196 | P00387 | |
| IPESHINKHLDSCLS | 211 | Q9NS91 | |
| HSGTESQAKHCIPEK | 301 | Q9Y2R2 | |
| CVEHHTFFQAKKLLP | 301 | P26045 | |
| DEHKRTHTGEKPFQC | 561 | Q9NQX1 | |
| HKKAIATLCFSPAHE | 391 | Q9UFC0 | |
| DCKFIETSAALHHNV | 226 | P55042 | |
| ECVKHLLQHKAPVDD | 346 | Q01484 | |
| KPAAKDVHLVDHCKY | 251 | Q8NBL1 | |
| PEKFTKVCEALEHGH | 301 | Q8N543 | |
| HLHFKNIVHCDLKPE | 696 | Q15139 | |
| QTCREEHKKKHPDAS | 21 | P09429 | |
| EHDPVTEFIAHCKSN | 571 | Q8IXH7 | |
| VFHRDKTKDTHPESC | 571 | Q9H3C7 | |
| ELHCDKLHVDPENFK | 91 | P02100 | |
| DKVNCTFISHHAIGK | 166 | Q9ULD2 | |
| KDHISTTAQDHCKAI | 121 | Q9H7X0 | |
| EKSHHKPKAAEVCQQ | 1046 | Q5T848 | |
| QTCREEHKKKHPDSS | 21 | P26583 | |
| LKLIHHDSKCDPGQA | 211 | Q9UBS5 | |
| AQSLEHDEHSCPFKK | 346 | O60291 | |
| HYSDHECSIVAEKLK | 246 | Q16206 | |
| EEKAHFCLEARQKHP | 971 | Q9BY66 | |
| LATTFPTCDLHEHGK | 546 | Q8NDZ0 | |
| EHCSLPEVLNHNLKK | 206 | Q5T1V6 | |
| VCTFLEKTETKSHPH | 1126 | Q5H9U9 | |
| GVLKKFTPHHLVNCD | 406 | P0C7V8 | |
| DVCNHEKKTADLAPH | 81 | Q9BPX6 | |
| NKRTDFHIPHACLKD | 146 | Q96RD9 | |
| KEAQAVLACFLDKHH | 111 | O60658 | |
| ADSCKASKTQAHAHP | 336 | Q9NTX9 | |
| KHIKTLSEAHEDCVN | 201 | Q5QP82 | |
| GVLKKFCPHHLVNSE | 371 | Q5TAQ9 | |
| EAKCEHLLASAKDEH | 806 | Q5T1M5 | |
| CIDSHLGEPHKFKRE | 146 | O15503 | |
| KCIPFLIGHLKDSTH | 236 | Q14D04 | |
| DEVHTKCQKLNPKSH | 1271 | O60449 | |
| AKHKHLCEELAETQG | 1796 | Q9ULI4 | |
| PPHSHASCAVEALKA | 296 | A6NGR9 | |
| LNTPLHLACSKGHEK | 906 | Q8N8A2 | |
| PKTAHIDVHFLKEGC | 651 | P23229 | |
| SAQCKKIHHDLTKDP | 116 | Q6ZWI9 | |
| ELTVHEAACAHPTKT | 181 | Q6ZMK1 | |
| VKIKCPEESASHLHV | 66 | O00254 | |
| KNHSEHPLCSEEALD | 1086 | Q9BX63 | |
| CEHPSHKETKLGEHA | 76 | Q8WX93 | |
| PAKKIREEELCHHSS | 451 | Q96HA1 | |
| EVEAAKKAHHAACKE | 151 | Q9UNF0 | |
| PHEALICKSERVHSK | 436 | P38398 | |
| GKFHHVEKSASCAPL | 196 | Q9ULW2 | |
| PECEHHQKDKEELSF | 631 | Q13315 | |
| AATPSCHLLHKKICE | 111 | Q13535 | |
| EHTFVFRLDHPKACK | 296 | Q9HCM4 | |
| LDTHHKLCTFILKNP | 131 | P55010 | |
| QDPPEHISLCHSAKK | 41 | Q7L8L6 | |
| PDQLKKEDSHCNIIH | 101 | Q9BVC3 | |
| PLLSDKHKHSRENSC | 1701 | Q8N1I0 | |
| HPSSKIAKENLDVFC | 491 | Q9UBT7 | |
| EEVLAAACHPVQHSK | 731 | P51587 | |
| VASAHTDGKIKILCH | 311 | Q8N0S6 | |
| IPCVLSLHKKCFHDD | 486 | P41002 | |
| HAARAKEAAASLPKH | 1096 | Q4ZHG4 | |
| ELHCDKLHVDPENFK | 91 | P69891 | |
| QAAKHEGPLHKCDIS | 531 | Q9BYF1 | |
| EKKAEAQNHHCVPDV | 386 | Q9BSJ5 | |
| QSDDPHFHEKKQIPC | 276 | P55210 | |
| SCHKTPDKVNHAVLA | 271 | P09668 | |
| GHTVKAVCESFHLAK | 261 | Q9H9T3 | |
| THVDKACKLGEARHP | 681 | Q13495 | |
| SEHLKSCPFNIVEHK | 661 | Q9UH90 | |
| FLDTCDLHTEHIKPS | 881 | Q7Z4H7 | |
| GPDHKHVKDAHLTCE | 701 | Q5T7N3 | |
| LKDVHTHGIACLAFD | 101 | Q05BV3 | |
| TSAHERKKPLSNCIH | 6576 | Q8NDH2 | |
| ELHCDKLHVDPENFK | 91 | P69892 | |
| LQPSKEACFLEHLHK | 1076 | Q9NZM4 | |
| REPDHTCKKEHVFIH | 56 | Q5GAN4 | |
| HTKRCKDLNTFLHEP | 61 | Q9H1E1 | |
| GCKVLHHTAKLPADL | 946 | Q9NZJ4 | |
| SFPKTNHHRQCLEKE | 291 | Q56UN5 | |
| KKHDFPVQAHSFLSC | 96 | A0A1W2PPM1 | |
| NAISFEHVCKPKVEH | 331 | Q7L1W4 | |
| HAAQVTCVAASPHKD | 166 | Q9BQA1 | |
| PELHKHILACASASD | 1346 | Q13029 | |
| SNAPAVDLDHKFRCK | 441 | Q9BVI0 | |
| LTDQHCVHKFHSLPK | 571 | Q8ND04 | |
| FLHLTPVAIKKHCEA | 111 | P82673 | |
| LGHVKHKLVCSPDFE | 376 | P05423 | |
| HKLVCSPDFESLLDH | 381 | P05423 | |
| LSPDNGKKRDLCDHH | 86 | Q9BYJ4 | |
| SAEEQDEKICIHHPS | 281 | Q8IWZ5 | |
| QHKAETPHGAEEECK | 211 | Q9Y6A5 | |
| ESKAHIHCSVKAENS | 176 | Q15465 | |
| SLKDAHVKSRTAPHC | 166 | Q9ULS5 | |
| KDVPHRCSTHFDAVA | 326 | Q9ULZ9 | |
| QDTEKEHHTPTILKC | 116 | Q8IZP6 | |
| KCEHDPHVLLAVAKL | 836 | O94906 | |
| QLLHICSEHFDSKEK | 611 | Q13200 | |
| VTNKCHPDQTKHLDF | 416 | Q5K651 | |
| IEENSLKHDIPCHSK | 581 | Q6P1X5 | |
| IKAFLSKHCADHPNN | 246 | Q9NXP7 | |
| PEACSEIKHEAFKNH | 586 | Q96Q15 | |
| PSDKQDKLHGCLEHL | 1211 | Q8TCU6 | |
| CPVHLFKDHVDNDKE | 66 | O15266 | |
| SLPACDHLHKNESVL | 36 | Q15475 | |
| CSSFLKFHPELSKEH | 3051 | O75592 | |
| KHFLKCPSSEDNVAI | 1041 | Q8NEZ3 | |
| CEHSPVDLSKVDLHF | 276 | Q2Y0W8 | |
| EHLHSASCQIKVFKP | 206 | Q9NZI6 | |
| LFHENKPSRKTLHTC | 61 | P49959 | |
| AHHPAAISTAKFCIQ | 276 | Q5JTH9 | |
| TAEEATKCINHLHKT | 456 | Q15424 | |
| EDPEHALHLCTKFAK | 1761 | Q9NRC6 | |
| KSALDPTPKHECHVS | 266 | Q9UK61 | |
| KHVHCLPAETNVSFK | 761 | Q8NFU7 | |
| HADVSKCPIHAAAEA | 236 | A6NFN9 | |
| LHTHDPNKETFKCEE | 111 | Q6DJT9 | |
| CLPGHKQVDHHSKDT | 176 | A6NCW0 | |
| CQAKLDIAFGTHHTK | 251 | Q9NUW8 | |
| HCALHDKAQIREKPS | 106 | Q8IWS0 | |
| LSAACSDADLHRHKK | 1221 | Q9H9J4 | |
| EALDVHTCKAPKNAD | 341 | P09544 | |
| HKRIHAGEKPFSCEE | 301 | Q3SXZ3 | |
| LHERAHTGEKPFECK | 381 | Q14592 | |
| KHLLTHSSEPAFLCA | 366 | Q96SZ4 | |
| NEHVKTHTEEKPFIC | 521 | Q96MU6 | |
| ECGKAHNHLIDSSIK | 571 | Q96N58 | |
| HCPKAFLSASDLRKH | 576 | Q96K58 | |
| CLPGHKQVDHHSKDT | 176 | A6NCW7 | |
| EKDKATKHCCIHLPD | 956 | O14924 | |
| FHCIDPNDSKHKRTD | 56 | Q15185 | |
| EHLHSASCQIKVFKP | 226 | Q12800 | |
| CLPGHKQVDHHSKDT | 176 | D6R9N7 | |
| FKSLHQVEISHCDAK | 216 | Q9Y2I1 | |
| HCDAKHIRGLVASKP | 226 | Q9Y2I1 | |
| HQSIHTGEKPHECKE | 271 | Q96SK3 | |
| CLPGHKQVDHHSKDT | 176 | A8MUK1 | |
| NLEAHLKECEHIKCP | 246 | Q6Q0C0 | |
| CLPGHKQVDHHSKDT | 176 | D6R901 | |
| CLPGHKQVDHHSKDT | 176 | D6RCP7 | |
| DVPKNHVIVDCTDKH | 41 | Q9NYK1 | |
| RDHCKVSKSAHSLQP | 541 | Q8IYW5 | |
| FKHSSPKIRSHAVAC | 191 | Q92973 | |
| DCFASDHAPHTLEEK | 1681 | P27708 | |
| HLKAHSVQKPFKCEE | 446 | Q14588 | |
| ECPKAFSQKSHLIIH | 351 | Q2M218 | |
| TEHQKIHVGLKPFEC | 231 | Q494X3 | |
| EHHEPLKLFCQKDQS | 101 | Q9Y577 | |
| QCLEEGKHSSHEVKA | 251 | Q9C026 | |
| CEKPLASAAAKAIHN | 511 | Q9Y5L0 | |
| HQRLHTGEKPFKCDA | 381 | Q9NYT6 | |
| CLPGHKQVDHHSKDT | 176 | C9JPN9 | |
| HPVTKHEFEDNKCLV | 596 | Q8IWR0 | |
| ECIFTKNSHFHPKQI | 916 | P86452 | |
| HQRLHSGEKPFKCEE | 496 | Q9UK13 | |
| SCLALHQKTHIGEKP | 361 | Q09FC8 | |
| CLPGHKQVDHHSKDT | 176 | Q0WX57 | |
| AEELPEKEHGKISCH | 266 | Q9BRR0 | |
| SPKSHAFAHESICAE | 261 | Q5JVG2 | |
| ANLACHHKLHTAEKP | 536 | P17035 | |
| CLPGHKQLDHHSKDT | 176 | P0C7H9 | |
| CLPGHKQVDHHSKDT | 176 | P0C7I0 | |
| DKHKHISDLENCLSS | 236 | Q6ZR37 | |
| RKKHEEAIHAVACHP | 721 | Q9NRL3 | |
| EAIHAVACHPSKALI | 726 | Q9NRL3 | |
| KLDAHLCKHTGERPF | 56 | Q92664 | |
| TDHIHTAEKPSECGK | 251 | Q8N859 | |
| CLPGHKQVDHHSKDT | 176 | Q6QN14 | |
| FKEKHCSANHTALIA | 1601 | Q9BXT5 | |
| SLETCCQKHKLFHPD | 296 | O43915 | |
| CKSILDVLFPKHFHQ | 2221 | O15050 | |
| IHTSEKPQCSEHGKA | 351 | Q2M3X9 | |
| HQKIHSGDRPFECKD | 421 | O75123 | |
| CLPGHKQVDHHSKDT | 176 | D6RA61 | |
| DIFSCHAVDNPKPHS | 921 | A3KMH1 | |
| ACLCSHDKLHPDKIS | 511 | Q86UV5 | |
| SHVAVKHTGAKPFAC | 666 | Q9H4Z2 | |
| HLKVHTTEKPFSCAE | 516 | Q6IV72 | |
| CLPGHKQVDHHSKDT | 176 | C9J2P7 | |
| CLPGHKQVDHHSKDT | 176 | D6RBQ6 | |
| CLPGHKQVDHHSKDT | 176 | Q6R6M4 | |
| TTCHAPGHEKTEDNK | 1641 | Q5T200 | |
| HAHAAEIKKCVTAVD | 1211 | O75962 | |
| CLPGHKQVDHHSKDT | 176 | D6RJB6 | |
| HTVEKPHELSKCVNV | 296 | P51508 | |
| HEVTHSGEKPFQCKE | 356 | Q8TF47 | |
| LQSFHTKEHPFKCNE | 636 | Q8WTR7 | |
| CLPGHKQVDHHSKDT | 176 | C9JVI0 | |
| VSELDKCHHLVTKFD | 201 | P07101 | |
| KCHHLVTKFDPDLDL | 206 | P07101 | |
| PCHRALFTSKSEHKD | 926 | Q9BYP7 | |
| SDQSKEHPQHLCEKC | 216 | Q8N2G6 | |
| QKFHAHKAVLAACSD | 51 | Q96NJ5 | |
| HEDKSPICDSAISVH | 186 | Q9HD90 |